Prasugrel Hydrochloride/Aspirin

盐酸普拉格雷/阿司匹林

Report date: 2022/01/14 13:23:58

Base Information

Drug NamePrasugrel Hydrochloride/Aspirin
Drug Alias Name阿司匹林/盐酸普拉格雷Prasugrel/AspirinAspirin/PrasugrelAspirin/Prasugrel Hydrochloride
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitorsPurinergic receptor P2Y12 antagonists
TargetsCyclooxygenasesPurinergic receptor P2Y12
Therapy Area/IndicationsAcute Coronary Syndrome
Global Approved IndicationsAcute Coronary Syndrome
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2016/01/01
Country/TerritoryIndia
CombinationsYes AspirinPrasugrel Hydrochloride
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesTorrent Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesTorrent Pharmaceuticals Ltd
Inactive CompaniesN/A
Active IndicationsAcute Coronary Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeC01
Related LinksN/A